The INAHTA Board of Directors is composed of a diverse representation of the INAHTA membership. The Board is responsible for guiding the overall direction and activities of the Network and Secretariat toward the implementation of the INAHTA Strategic Plan. The members of the Board are representatives of an INAHTA member agency and they are elected by the membership for 2-year terms.
INAHTA Board Members
Alric Rüther, Dr. med, IQWiG, Germany, Chair (2024-2026)
Dr. Mouna Jameleddine, INEAS, Tunisia, Vice-Chair (2024-2026)
Jenny Berg, PhD, SBU, Sweden, Director (2024-2026)
Dr. Juan Antonio Blasco Amaro, AETSA, Spain, Director (2024-2026)
Irena Guzina, PharmD, HAS, France, HAS, France, Director (2023-2025)
Rosa Maria Vivanco Hidalgo, PhD, AQuAS, Spain, Director (2023-2025)
Juliana Yi, Ontario Health, Canada, Director (2024-2026)
Ex Officio: Prof. Tracy Merlin, AHTA, Australia, Past-Chair (2023-2025)
-> View Board member profiles below
-> View Board Competing and Conflict of Interest (CCI) forms below
Alric Ruether, Dr. Med, IQWiG, Germany
Chair (2024-2026)
View profile
View CCI Form
Dr. Mouna Jameleddine, INEAS, Tunisia
Vice-Chair (2024-2026)
View profile
View CCI Form
Jenny Berg, PhD, SBU, Sweden
Director (2024-2026)
View profile
View CCI Form
Dr. Juan Antonio Blasco Amaro, AETSA, Spain
Director (2024-2026)
View profile
View CCI Form
Irena Guzina, PharmD, HAS, France
Director (2023-2025)
Rosa Maria Vivanco Hidalgo, PhD, AQuAS, Spain
Director (2023-2025)
Juliana Yi, Ontario Health, Canada
Director (2024-2026)
Prof. Tracy Merlin, AHTA, Australia
Past-Chair (2023-2025)